» Articles » PMID: 31856259

Chronic Unexplained Nausea in Adults: Prevalence, Impact on Quality of Life, and Underlying Organic Diseases in a Cohort of 5096 Subjects Comprehensively Investigated

Overview
Journal PLoS One
Date 2019 Dec 20
PMID 31856259
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated to define the clinically significant chronic nausea in general population and to assess the prevalence of chronic unexplained nausea after exclusion of organic causes through the meticulous medical examination. Two phase studies were conducted. In phase 1, telephone survey was conducted to define the clinically significant nausea in 5000 representative subjects for a general population. Clinically significant nausea was identified by lowered quality of life if the frequency was 'more than one day per week'. Its prevalence was 1.6% (1.4-1.8%) and about 90% of nausea was not accompanied with vomiting. In phase 2, 5096 participants in a comprehensive health-screening cohort were enrolled. We investigated demographics, gastrointestinal symptoms, somatization symptoms and health related quality of life using validated questionnaire. All participants underwent meticulous medical examinations including endoscopy, abdominal ultrasound, thyroid function test, and blood testing. Among a total of 5096 subjects (men 51.8%, mean age 47.5 ± 10.0 years), organic diseases associated with chronic nausea were reflux esophagitis, duodenal ulcer and hyperthyroidism. The prevalence of chronic unexplained nausea was 0.6% (95% CI 0.4-0.8%) and there were significant overlap with functional dyspepsia and irritable bowel syndrome. HRQoL is significantly lower in people with nausea occurring 'more than one day per week' in a general population. Most chronic nausea was not accompanied with vomiting. Chronic unexplained nausea is uncommon affecting only 0.6% of the population but are more likely to report functional dyspepsia and irritable bowel syndrome.

Citing Articles

Approach to Meal-Related Nausea and Vomiting.

Cangemi D, Chase R, Lacy B Gastroenterol Hepatol (N Y). 2025; 21(1):19-27.

PMID: 39897340 PMC: 11784569.


Comprehensive insights on treatment modalities with conventional and herbal drugs for the treatment of duodenal ulcers.

Hameed H, Hussain J, Paiva-Santos A, Zaman M, Hamza A, Sajjad I Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8211-8229.

PMID: 38837070 DOI: 10.1007/s00210-024-03178-5.


Epigenomic Links Between Social Determinants of Health and Symptoms: A Scoping Review.

Ray M, Wallace M, Grayson S, Cummings M, Davis J, Scott J Biol Res Nurs. 2022; 25(3):404-416.

PMID: 36537264 PMC: 10404910. DOI: 10.1177/10998004221147300.


Gastric dysfunction in patients with chronic nausea and vomiting syndromes defined by a noninvasive gastric mapping device.

Gharibans A, Calder S, Varghese C, Waite S, Schamberg G, Daker C Sci Transl Med. 2022; 14(663):eabq3544.

PMID: 36130019 PMC: 10042458. DOI: 10.1126/scitranslmed.abq3544.

References
1.
Tack J, Talley N, Camilleri M, Holtmann G, Hu P, Malagelada J . Functional gastroduodenal disorders. Gastroenterology. 2006; 130(5):1466-79. DOI: 10.1053/j.gastro.2005.11.059. View

2.
Pasricha P, Colvin R, Yates K, Hasler W, Abell T, Unalp-Arida A . Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011; 9(7):567-76.e1-4. PMC: 3123425. DOI: 10.1016/j.cgh.2011.03.003. View

3.
Hajek P, Lewis S, Munafo M, Lindson N, Coleman T, Aveyard P . Mediators of the effect of nicotine pre-treatment on quitting smoking. Addiction. 2018; 113(12):2280-2289. DOI: 10.1111/add.14401. View

4.
Meyer K . Gastroesophageal reflux and lung disease. Expert Rev Respir Med. 2015; 9(4):383-5. DOI: 10.1586/17476348.2015.1060858. View

5.
Lacy B, Parkman H, Camilleri M . Chronic nausea and vomiting: evaluation and treatment. Am J Gastroenterol. 2018; 113(5):647-659. DOI: 10.1038/s41395-018-0039-2. View